We are honored to announce the 15th Professor Edwaldo Camargo Symposium - PET/CT and SPECT/CT in Oncology - TERANOSTICS edition, to be held on March 25 to 27, 2020 in Campinas, São Paulo, Brazil.
The MND Campinas group addresses annually a relevant theme of Nuclear Medicine in Oncology. In this edition, we will cover THERANOSTICS in Nuclear Medicine - relevant topics related to therapy associated with diagnosis, with one full day devoted to prostate cancer; the second day devoted entirely to neuroendocrine tumors and radioembolization; and the third day dedicated to thyroid cancer and radiosynovectomy.
We will have five (5) internationally renowned speakers.
This event has a multidisciplinary approach and for this reason, we invite nuclear medicine physicians, radiologists, oncologists, radiotherapists, urologists, endocrinologists, oncology surgeons, orthopedists, rheumatologists, residents, academics as well as physicists, technologists and radiopharmacists.
The event honors in memoriam Professor Edwaldo Camargo, the pioneer in PET/CT in Brazil and the event is also promited by the Division of Nuclear Medicine of the University of Campinas.
We hope to see you soon!
Warm regards,
Elba Etchebehere
Allan Santos
Celso Darío Ramos
Mariana Lima
Committees
Dr. Hojjat Ahmadzadehfar is a professor and head of the therapy section of the Bonn University Department of Nuclear Medicine. He has been the assistant medical director of the Department of Nuclear Medicine at Bonn University Hospital and, since 2013, has served as head of the therapy section. Dr. Ahmadzadehfar serves as editor and reviewer for several international journals and has written and co-written over 130 book articles and chapters.
Dr. Hojjat Ahmadzadehfar is a professor and head of the therapy section of the Bonn University Department of Nuclear Medicine. He has been the assistant medical director of the Department of Nuclear Medicine at Bonn University Hospital and, since 2013, has served as head of the therapy section. Dr. Ahmadzadehfar serves as editor and reviewer for several international journals and has written and co-written over 130 book articles and chapters.
Dr. Liepe is a nuclear medicine and pediatric specialist, Head of the Department of Nuclear Medicine in the Frankfurt (Oder) Hospital and the administrative director of the Center of Medical Care GmbH, Kassel Hospital. Dr. Liepe has 22 years' experience in radiosynovectomy, having treated over 20,000 joints. He also has 22 years' experience in pain palliation using rhenium-188-HEDP, rhenium-186-HEDP, strontium-89, samarium-153-EDTMP, radium-223; and combination with chemotherapy dosimetry, 99mTc-Tectrotyd, SIRT, rhTSH in treatment of thyroid cancer and pediatric nuclear medicine.
Dr. Liepe is a nuclear medicine and pediatric specialist, Head of the Department of Nuclear Medicine in the Frankfurt (Oder) Hospital and the administrative director of the Center of Medical Care GmbH, Kassel Hospital. Dr. Liepe has 22 years' experience in radiosynovectomy, having treated over 20,000 joints. He also has 22 years' experience in pain palliation using rhenium-188-HEDP, rhenium-186-HEDP, strontium-89, samarium-153-EDTMP, radium-223; and combination with chemotherapy dosimetry, 99mTc-Tectrotyd, SIRT, rhTSH in treatment of thyroid cancer and pediatric nuclear medicine.
Professor Mike Sathekge is head of the Nuclear Medicine department at the University of Pretoria. He is President of the Medical Research Council of South Africa.
He introduced several technologies in South Africa. Mike's research efforts to advance molecular imaging and the development of clinical applications have contributed to clinical and physiological studies on the role of PET / CT in patients suffering from HIV / AIDS and tuberculosis.
Prof. Mike has vast experience with prostate cancer treatment with 225Ac-PSMA.
Professor Mike Sathekge is head of the Nuclear Medicine department at the University of Pretoria. He is President of the Medical Research Council of South Africa.
He introduced several technologies in South Africa. Mike's research efforts to advance molecular imaging and the development of clinical applications have contributed to clinical and physiological studies on the role of PET / CT in patients suffering from HIV / AIDS and tuberculosis.
Prof. Mike has vast experience with prostate cancer treatment with 225Ac-PSMA.
Dr. Onófrio Catalano is a Radiologist at Massachusetts General Hospital, Boston, MA, USA.
He graduated at the Federico II University of Naples, his first experience at Harvard dates back to 1998 as a visiting researcher at Massachusetts Hospital in Boston.
Until 2008 he was medical director of the "Gaetano Rummo" hospital in Benevento, Italy.
In 2010 obtained the title of associate professor at the University of Naples.
Since 2012, he has focused his research on PET/MRI, mainly with applications in the field of abdominal imaging and oncology.
Since 2015, he has continued his investigations at Massachusetts General Hospital in Boston, USA, with the aim of improving the care of cancer patients.
Dr. Onófrio Catalano is a Radiologist at Massachusetts General Hospital, Boston, MA, USA.
He graduated at the Federico II University of Naples, his first experience at Harvard dates back to 1998 as a visiting researcher at Massachusetts Hospital in Boston.
Until 2008 he was medical director of the "Gaetano Rummo" hospital in Benevento, Italy.
In 2010 obtained the title of associate professor at the University of Naples.
Since 2012, he has focused his research on PET/MRI, mainly with applications in the field of abdominal imaging and oncology.
Since 2015, he has continued his investigations at Massachusetts General Hospital in Boston, USA, with the aim of improving the care of cancer patients.
Dr. Ulrike Garske Román is an MDPhD and works at the Sahlgrenska University Hospital, Gothenburg, Sweden.
Dr. Ulrike has a vast experience and researches in neuroendocrine tumors especially paragangliomas & neuroblastomas, from diagnosis to treatment with radioisotopes.
Dr. Ulrike was Senior Consultant (2010-2016) in the Radiology, Oncology and Radiation Science Department of the Uppsala University in Sweden.
Dr. Ulrike is a Senior Consultant (since 2014) at the Sahlgrenska University Hospital Gothenburg, Sweden.
Dr. Ulrike Garske Román is an MDPhD and works at the Sahlgrenska University Hospital, Gothenburg, Sweden.
Dr. Ulrike has a vast experience and researches in neuroendocrine tumors especially paragangliomas & neuroblastomas, from diagnosis to treatment with radioisotopes.
Dr. Ulrike was Senior Consultant (2010-2016) in the Radiology, Oncology and Radiation Science Department of the Uppsala University in Sweden.
Dr. Ulrike is a Senior Consultant (since 2014) at the Sahlgrenska University Hospital Gothenburg, Sweden.
Vitória Hotel Concept Campinas
Avenida José de Sousa Campos, 425, Campinas / São Paulo, Brasil
+55 (19) 3755-8000 | +55 (19) 99704-9300
https://www.vitoriahoteis.com.br/hotel-concept-campinas_/
Valet parking service at the Hotel
20 hours
On-line participation certificate provided.
Nuclear doctors, oncologists, radiologists, radiotherapists. Residents, medical students, biomedics, urologists and endocrinologists.
MND Campinas
Sponsors
Supporters
Executive secretariat
